Oxidative stress has been implicated as an important mechanism of vascular endothelial dysfunction induced by aging. Previous studies suggested that tetrahydrobiopterin (BH 4), an essential cofactor of endothelial NO synthase, could be a molecular target for oxidation. We tested the hypothesis that oxidative stress, in particular oxidation of BH 4, may contribute to attenuation of endothelium-dependent relaxation in aged mice. Vasomotor function of isolated carotid arteries was studied using a video dimension analyzer. Vascular levels of BH 4 and its oxidation products were measured via HPLC. In aged mice (age, 95 Ϯ 2 wk), endothelium-dependent relaxation to ACh (10 Ϫ5 to 10 Ϫ9 M) as well as endothelium-independent relaxation to the NO donor diethylammo-
endothelial dysfunction; nitric oxide; superoxide anion; reactive oxygen species; C-reactive protein AGING IS A RISK FACTOR for vascular disease; however, the role of aging, either as a process or as the result of longer exposure to other risks, is not well defined (16, 17) . In murine vascular tissue, the age-dependent changes in vasomotor function have not been characterized. Studies on rats have shown impairment of endothelium-dependent relaxation due to increased production of superoxide anions, but the source of the superoxide anions has also not been characterized (16, 30) . Reactive oxygen species (ROS) have been implicated in endothelial dysfunction associated with aging, hypertension, hypercholesteremia, diabetes, and cigarette smoking (3) . ROS can interfere with endothelium-dependent relaxation particularly by the scavenging of NO by superoxide anion (O 2 Ϫ ⅐; Refs. 1, 3, 34) .
Additionally, the product of this reaction, peroxynitrite, is a potent but selective oxidant in vitro and in vivo and can cause cytotoxic damage, which could contribute to the pathology of vascular disease (1, 28) .
One possible target for oxidation by peroxynitrite is tetrahydrobiopterin (BH 4 ), which is an essential cofactor of all NO synthase (NOS) isoforms. During biosynthesis of NO, BH 4 prevents the uncoupling of the electron transfer from NADPH to L-arginine and the subsequent production of O 2 Ϫ ⅐ (4, 32, 35, 36). Recently BH 4 was shown to inhibit O 2 Ϫ ⅐ production by endothelial NOS (eNOS), whereas the oxidized analog 7,8-dihydrobioterin (7, ) potentiated O 2 Ϫ ⅐ production by eNOS (33) . In addition, BH 4 can autoxidize in a radical chain reaction; this could result in the reduction of available cofactors and the contribution of more oxidants to the milieu (14) . Finally, peroxynitrite can oxidize BH 4 (18, 21, 22) . Therefore, reduced BH 4 levels can reflect increased oxidative stress as well as contribute to generation of ROS. In this study, we tested the hypothesis that oxidation of BH 4 is responsible for aging-induced endothelial dysfunction.
METHODS
Experimental animals. Male C57BL/6 mice were used for all experiments. Young animals were 20 -27 wk, and aged animals were 84 -114 wk of age. All mice were fed regular pelleted diet and housed in facilities with a 12:12-h light-dark cycle. Experimental protocols and housing facilities were approved by the Institutional Animal Care and Use Committee of the Mayo Clinic.
The mice were killed with a 60 mg/kg ip injection of pentobarbital. Blood samples were obtained via puncture of the right ventricle. The blood was mixed with heparin and centrifuged at 4°C for 10 min at 2,000 rpm. The plasma was aspirated and stored at Ϫ80°C. Cholesterol levels were determined using a colorimetric-based assay on a Cobras Mira system. The aorta, carotid arteries, and kidney were removed and placed immediately in ice-cold modified Krebs-Ringer solution that contained (in mM) 118.3 NaCl, 4.7 KCl, 2.5 CaCl 2, 1.2 MgSO4, 1.2 KH2PO4 (monobasic), 25 NaHCO3, 11.1 dextrose, and 0.028 calcium disodium versenate. Carotid arteries were dissected, and connective tissue was removed under a microscope (Carl Zeiss; Oberkochen, Germany). Aorta and kidneys were prepared similarly using a lighted magnifying glass. All of the assays were performed using tissue from the same animal.
Vasomotor reactivity. Carotid arteries were studied individually using a microcannula technique that has been previously described (8) . Briefly, each artery was sutured to two microcannulas and placed in a vessel chamber (Living Systems Instrumentation; Burlington, VT) filled with aerated (94% O 2-6% CO2) Krebs-Ringer solution at 37°C, which flowed from a 250-ml reservoir to the vessel chamber at a rate of 50 ml/min. A pressure of 50 mmHg was maintained in the artery through the microcannulas. The arteries were equilibrated 45 min before each experiment. The arteries were submaximally contracted with the thromboxane analog 9,11-dideoxy-11␣,9␣-epoxymethanoprostaglandin F 2␣ (U-46619, 10 Ϫ7 to 10 Ϫ6 M), and endothelium-dependent relaxation was then obtained using ACh (10 Ϫ9 to 10 Ϫ5 M). After washout, equilibration, and submaximal contraction of the arteries with U-46619, endothelium-independent relations were determined using diethylammonium (Z)-1-(N,N-diethylamino)diazen-1-ium-1,2-diolate (DEA-NONOate, 10 Ϫ9 to 10 Ϫ5 M). Relaxation values were determined as percents of relaxation to a high concentration of papaverine (3 ϫ 10 Ϫ4 M). In a separate protocol, arteries were preincubated with the SOD mimetic Mn(III)tetra(4-benzoic acid)porphyrin chloride (MnTBAP, 10 Ϫ5 M) 15 min before contraction (8) .
Biopterin measurements. Fresh aortas were used for analysis. Aortas were homogenized in extraction buffer that contained (in mM) 50 Tris ⅐ HCl (pH 7.4), 1 EDTA, and 10 1,4-dithio-(DL)-threitol using a glass mortar and pestle (Kontes; Vineland, NJ; Ref. 7) . The homogenate was centrifuged at 4°C and 10,000 rpm for 10 min, and the resulting supernatant was used in the assay. Amounts of reduced BH 4 and total oxidized biopterins including 7,8-BH2 levels were measured after oxidation in acid and base conditions using reverse-phase HPLC (7, 9) .
Detection of vascular O 2 Ϫ ⅐ production. O 2 Ϫ ⅐ production was measured by lucigenin-enhanced chemiluminescence as previously described (7). Briefly, aortas were opened lengthwise and equilibrated for 30 min at 37°C in modified Krebs-HEPES buffer (pH 7.4). Scintillation vials that contained 2 ml of Krebs-HEPES buffer with 5 M lucigenin were placed into a scintillation counter (LS 5000; Beckman Instruments) that was switched to the out-of-coincidence mode. Background signals were recorded, and vascular segments were then added to each vial. The results were expressed as counts per minute per milligram of dry weight.
Measurement of GTP cyclohydrolase I activity. GTP cyclohydrolase I (GTPCH-I) activity was determined by standardized enzymatic reaction followed by oxidation as previously described with small modifications (31) . Concisely, 100 l of tissue supernatant homogenate, prepared as in the biopterin assay, was filtered using a Sephadex G25M column (Amersham; Piscataway, NJ) to remove endogenous neopterin, BH4, and phenylalanine. The resulting supernatant was then incubated at 37°C for 2 h in a mix that contained 7.14 mM Tris ⅐ HCl, 21.4 mM KCl, 0.179 mM EDTA (disodium, dihydrate), 96.9 mM glycerol, 0.714 g of bovine serum albumin, 7.14 M PMSF (in isopropanol, 933 mM), and 0.819 mM GTP. Once the reaction was terminated with the addition of 10 l of 1 M HCl on ice, the resulting reaction product was oxidized with 10 l of an iodine reagent (1% I2, 2% KI) for 1 h in the dark. This reaction was stopped with 10 l of 20% ascorbate solution. The neopterin triphosphate was converted to neopterin for analysis by adding 20 l of 1 M NaOH and 10 l of 2,500 U/ml alkaline phosphatase in 37.5 mM MgCl2 and reacting at 37°C for 1 h. The product was analyzed as the biopterin using reverse-phase HPLC. All results were standardized to the protein concentration and assayed using DC Protein Assay (Bio-Rad; Hercules, CA) based on the Lowry method (19) .
Measurement of serum amyloid P component. The serum amyloid P component (SAP) values were measured using an ELISA method (2) . Briefly, SAP protein in plasma from mice was captured onto a 96-well microplate that was previously coated with a sheep antimouse polyclonal antibody (catalog no. 565194; Calbiochem; La Jolla, CA). For detection of captured SAP protein, a rabbit antimouse SAP antibody (catalog no. 565192; Calbiochem) was employed as a primary antibody followed by a horseradish peroxidase-conjugated, goat anti-rabbit IgG antibody (catalog no. DC03L, Calbiochem) as a secondary antibody and tetramethylbenzidine as the peroxidase substrate (catalog no. 555214; BD Pharmingen; San Diego, CA). Developed color was detected at a 450-nm wavelength using an absorbance plate reader and was quantified against a reference curve constructed using a mouse SAP standard (catalog no. 565192; Calbiochem).
Determination of senescence. Bisected kidneys were embedded in optimal cutting temperature compound (Sakura; Torrance, CA) and frozen at Ϫ80°C until sectioning. The tissue was cut in 5-m sections, and senescence was determined using the senescence ␤-Galactosidase Staining Kit (Cell Signaling Technology; Beverly, MA).
Drugs. ACh hydrochloride was obtained from Sigma Chemical (St. Louis, MO). DEA-NONOate and U-46619 were purchased from Cayman Chemical (Ann Arbor, MI), and MnTBAP was obtained from BIOMOL Laboratories (Plymouth Meeting, PA) .
Statistical analysis. All data are reported as means Ϯ SE. SigmaStat was used to perform all statistical analyses, which were preceded by a test for normality. For comparison between two groups, MannWhitney tests or t-tests were performed where needed. Dose-response curves were compared using two-way ANOVA for repeated measures. Comparisons of multiple groups were made using a one-way ANOVA. All ANOVAs were followed with Bonferroni's correction. P Ͻ 0.05 was considered significant. Because all arteries did not relax to at least 50%, EC25 values were used.
RESULTS
Animal characteristics. There were no differences observed between the animals with regard to plasma concentrations of glucose, cholesterol, high-density lipoprotein, or triglycerides (Table 1) . Additionally, there were no changes in body weight or in basal diameter and wall thickness of the carotid artery. Senescence-associated ␤-galactosidase staining of kidney was present in the aged animals (data not shown).
Vascular reactivity. There was no statistical difference between young and aged animals in the submaximal contractions of carotid arteries to U-46619 (Table 1) . Maximum endotheliumdependent relaxations to ACh were reduced in aged mouse carotid arteries compared with young animals. Preincubation with MnTBAP significantly improved relaxation such that the maximum values for both the young and the aged mouse carotids were no longer different (Table 2 and Fig. 1 ). There was no difference between young mouse carotids treated with and without MnTBAP (Fig. 1A) . Similar results were obtained Values except age ranges are means Ϯ SE; n, no. of mice, shown in parentheses. U-46619, 9,11-dideoxy-11␣-9␣-epoxymethanoprostaglandin F2␣. *P Ͻ 0.05 compared with young mice.
for the endothelium-independent relaxations to DEA-NONOate (Fig. 2) .
The EC 25 values of aged mouse arteries in response to both ACh and DEA-NONOate were significantly increased (Table   3 ). There was no difference observed between the young and the aged mouse arteries with the addition of MnTBAP.
Vascular O 2 Ϫ ⅐ production. Formation of O 2 Ϫ ⅐ was increased approximately fivefold in aged mouse aortas (young, 11,208 Ϯ 4,373; aged, 60,239 Ϯ 16,515 counts⅐min Ϫ1 ⅐mg of dry weight Ϫ1 ; n ϭ 4; P Ͻ 0.05). Values are means Ϯ SE; *n ϭ 4 mice, †n ϭ 6 mice. MnTBAP, Mn(III)-tetra(4-benzoic acid)porphyrin chloride; DEA-NONOate, diethylammonium-(Z)-1-(N,N-diethylamino)diazen-1-inm-1,2-diolate. ‡P Ͻ 0.05 vs. aged mice treated with same drug (ANOVA) and Bonferroni's test). Biopterin levels and GTPCH-I activity. There were no significant differences between young and aged mouse aortas in BH 4 concentrations (Fig. 3A) or in combined 7,8-BH 2 and biopterin concentrations (Fig. 3B) . The ratios of BH 4 to 7,8-BH 2 and biopterin were unchanged (Fig. 3C) . There was also no change in GTPCH-I activity in the aorta of aged mice (Fig. 4) .
Serum concentration of SAP. Levels of circulating SAP were significantly higher in aged compared with young mice (307 Ϯ 167 vs. 16 Ϯ 7 g/ml, respectively; n ϭ 6 mice; P Ͻ 0.05).
DISCUSSION
This is the first study to examine the effects of aging on endothelium-dependent relaxation in mice. Aging significantly reduced relaxation to ACh mediated by release of NO from endothelial cells. Furthermore, relaxation in response to the NO donor DEA-NONOate was also reduced in aged mouse arteries, which indicates that impaired reactivity of smooth muscle cells to NO is an important component of endothelial dysfunction of aged mouse arteries. The SOD mimetic MnTBAP normalized vasomotor function of carotid arteries, which suggests that chemical antagonism between O 2 Ϫ ⅐ and NO is responsible for impairment of relaxation in response to ACh and DEA-NONOate. We also provide evidence that in a murine model of aging, alterations of BH 4 metabolism do not contribute to impaired vasomotor function.
Vascular endothelium plays an essential role in cardiovascular homeostasis. Consistent with the results of the present experiments, numerous previous studies demonstrated that endothelium becomes dysfunctional in aged mouse arteries, mostly due to loss of NO biological activity and/or biosynthesis (10, 12, 13, 15, 20, 23, 30) . Pharmacological analysis of impaired endothelium-dependent relaxation in response to ACh in aged mouse arteries demonstrated that reactivity of smooth muscle cells to NO is also reduced. This reduction is an important mechanism that underlies impairment of relaxation induced by the release of NO from endothelium. The ability of the SOD mimetic MnTBAP to normalize relaxation in response to ACh and DEA-NONOate in aged mouse arteries strongly suggests that increased production of O 2 Ϫ ⅐ and subsequent chemical inactivation of NO are critical mechanisms of vasomotor dysfunction in aged arteries. Indeed, measurements of O 2 Ϫ ⅐ production demonstrated increased formation of this Fig. 4 . GTP cyclohydrolase I (GTPCH) activity, measured as production of neopterin under standard conditions, in young and aged C57BL/6 mouse aortas. There was no difference in the activity of this enzyme between young and aged mice. free radical in aortas of old mice. The selectivity of MnTBAP was indicated by the fact that it did not affect relaxation in response to ACh or DEA-NONOate in young arteries. Consistent with our findings, van der Loo et al. (30) previously demonstrated that endothelial dysfunction in aortas of aged rats was due to increased production of O 2 Ϫ ⅐. Interestingly, in aged rats, increased production of O 2 Ϫ ⅐ was detected in endothelial cells but not in smooth muscle cells. In contrast, in the present study, MnTBAP normalized endothelium-independent relaxation induced by NO. This finding suggests that in the carotid arteries of aged mice, O 2 Ϫ ⅐ is present not only in the endothelium but also in the media. This conclusion is consistent with the fact that in carotid arteries of Cu,Zn-SOD-knockout mice, which have increased O 2 Ϫ ⅐ throughout the vascular wall, both endothelium-dependent relaxation in response to ACh and endothelium-independent relaxation in response to NO are impaired (6) .
Examination of various parameters, including plasma glucose level and lipid profile, demonstrated that there were no differences between young and aged animals, which rules out a possible contribution of age-induced metabolic changes to vasomotor dysfunction. Furthermore, measurements of basal diameter and wall thickness of the carotid artery did not differ between young and aged animals, which excludes major ageinduced remodeling of the arterial wall as an explanation for the observed differences in vasomotor function. In aged animals, we detected senescence-associated ␤-galactosidase staining in the kidneys, which indicates that the mice used in the present study were of an age at which cells were senescent. Interestingly, serum SAP levels were significantly increased in aged mice. SAP is the murine analog of C-reactive protein (33) , which is an important proinflammatory marker in humans. This observation is consistent with the concept that aging is associated with increased production of proinflammatory mediators, including O 2 Ϫ ⅐. Several in vitro studies demonstrated that BH 4 can be inactivated by peroxynitrite-induced oxidation (18, 21, 22) . Simultaneous production of NO and O 2 Ϫ ⅐ in aged arteries provides favorable conditions for biosynthesis of peroxynitrite. Indeed, existing evidence suggests that increased production of peroxynitrite is an important mechanism of age-induced oxidative stress (30) . If the cellular concentration of BH 4 is reduced to a level suboptimal to that required for enzymatic activity of NOS, this may have inhibitory effect on NO production. Furthermore, uncoupling of NO synthesis from consumption of NADPH may lead to NOS-mediated reduction of oxygen and formation of O 2 Ϫ ⅐ (4, 32, 36, 37). This has been proposed as an important mechanism underlying endothelial dysfunction caused by hypercholesterolemia, hypertension, diabetes, and smoking (5, 11, 24 -27, 29, 37) . Based on these considerations, we hypothesized that BH 4 oxidation may be an important component of endothelial dysfunction that is developed as a result of aging. In contrast with our expectations, we did not detect any major change in BH 4 metabolism in aged mouse vascular tissue. Levels of both BH 4 and its oxidation products were not different between young and aged mouse tissues. These findings strongly suggest that BH 4 is not a molecular target for oxidation by an age-induced increase in oxidative stress. Our conclusion was reinforced by the fact that enzymatic activity of GTPCH-I, which is a rate-limiting enzyme in BH 4 biosynthesis, was not affected by aging.
The results of the present study suggest that in mouse carotid arteries, aging-induced impairment of reactivity to NO is due to increased formation of O 2 Ϫ ⅐. Aging apparently does not affect BH 4 metabolism in vascular tissue. Therefore, oxidation of BH 4 appears to be an unlikely mechanism responsible for vascular dysfunction of aged carotid arteries.
